Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults.

Publication date: Feb 05, 2025

Concepts Keywords
3rd Adjuvant
Driving Advax-CpG
Nct05542862 COVID-19
Nuclear Delta inulin
Vaccine Pandemic
SARS-CoV-2
Vaccine

Semantics

Type Source Name
disease IDO protein
disease MESH breakthrough infections
disease MESH long COVID
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection

Original Article

(Visited 2 times, 1 visits today)